red blue and green graphic. Text reads "reflecting on 2024" and features artwork from the TOPPLE Study, T1D RELAY Study, and JAKPOT T1D study positioned on a timeline
Media Release
Read more
Reflecting on 2024 with TrialNet Chair Kevan Herold, MD
As we begin a new year, it’s the perfect time to celebrate our accomplishments. We recently spoke with TrialNet Chair Kevan Herold, MD, to get his insights on the past year and plans for the year ahead. Dr. Herold is a professor of immunobiology and medicine at Yale University, one of 17 TrialNet Clinical Centers at the forefront of type 1 diabetes research.
The Tremblay family (Laura, 2nd from right; Bella, far left).
Participant Spotlight
Read more
Meet Laura Tremblay: Former screening skeptic turned advocate
The Tremblay family (Laura, 2nd from right; Bella, far left).
Laura Tremblay’s type 1 diabetes (T1D) journey began in 2018, when her 9-year-old daughter, Bella, was admitted to the hospital in diabetic ketoacidosis (DKA). Like many families without a history of T1D, the Tremblays didn’t recognize the symptoms.
8 photos of TrialNet participants around text. Center text reads "250,000 screened for T1D autoantibodies" and has confetti over it.
Media Release
Read more
Type 1 diabetes community celebrates research milestone during National Diabetes Month
More than a quarter million people screened for risk
Sign up here to join our mailing list for the latest updates on important T1D research and events, straight to your inbox. You can also find us on Facebook @DiabetesTrialNet.
